Joseph Shulman insider trades: Rhythm Pharmaceuticals (RYTM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | RYTM | ↓ Sell | 5,079 | $119.75 | $608K | Direct | Aug 17, 2026 (4d) |
| Oct 30, 2025 | RYTM | ↓ Sell | 9,748 | $115.24 | $1.1M | Direct | Nov 3, 2025 (4d) |
| Oct 28, 2025 | RYTM | ↓ Sell | 2,815 | $115.01 | $324K | Direct | Oct 30, 2025 (2d) |
| Oct 16, 2025 | RYTM | ↓ Sell | 14,437 | $112.03 | $1.6M | Direct | Oct 20, 2025 (4d) |
| Sep 2, 2025 | RYTM | ↓ Sell | 16,781 | $105.30 | $1.8M | Direct | Sep 4, 2025 (2d) |
| Aug 21, 2025 | RYTM | ↓ Sell | 4,188 | $100.07 | $419K | Direct | Aug 25, 2025 (4d) |
| Aug 11, 2025 | RYTM | ↓ Sell | 3,984 | $90.08 | $359K | Direct | Aug 13, 2025 (2d) |
| Jul 9, 2025 | RYTM | ↓ Sell | 7,969 | $77.78 | $620K | Direct | Jul 11, 2025 (2d) |
| Feb 19, 2025 | RYTM | ↓ Sell | 1,228 | $57.22 | $70K | Direct | Feb 19, 2025 (0d) |
| Feb 12, 2025 | RYTM | ↓ Sell | 469 | $56.40 | $26K | Direct | Feb 14, 2025 (2d) |
| Feb 11, 2025 | RYTM | ↓ Sell | 794 | $57.51 | $46K | Direct | Feb 11, 2025 (0d) |
| Feb 4, 2025 | RYTM | ↓ Sell | 1,281 | $59.43 | $76K | Direct | Feb 4, 2025 (0d) |
| Nov 11, 2024 | RYTM | ↓ Sell | 13,281 | $66.44 | $882K | Direct | Nov 13, 2024 (2d) |
| Jul 16, 2024 | RYTM | ↓ Sell | 10,468 | $53.00 | $555K | Direct | Jul 18, 2024 (2d) |
| Jul 12, 2024 | RYTM | ↓ Sell | 5,313 | $50.01 | $266K | Direct | Jul 16, 2024 (4d) |
| May 9, 2024 | RYTM | ↓ Sell | 3,984 | $38.47 | $153K | Direct | May 13, 2024 (4d) |
| Mar 21, 2024 | RYTM | ↓ Sell | 18,235 | $40.34 | $736K | Direct | Mar 22, 2024 (1d) |
| Mar 19, 2024 | RYTM | ↓ Sell | 15,515 | $39.22 | $608K | Direct | Mar 19, 2024 (0d) |
| Feb 14, 2024 | RYTM | ↓ Sell | 2,954 | $50.00 | $148K | Direct | Feb 15, 2024 (1d) |
| Feb 13, 2024 | RYTM | ↓ Sell | 73,038 | $50.39 | $3.7M | Direct | Feb 13, 2024 (0d) |
| Feb 1, 2024 | RYTM | ↓ Sell | 1,324 | $45.06 | $60K | Direct | Feb 5, 2024 (4d) |
| Dec 28, 2023 | RYTM | ↓ Sell | 12,941 | $50.00 | $647K | Direct | Dec 29, 2023 (1d) |
| Nov 14, 2023 | RYTM | ↓ Sell | 27,890 | $32.07 | $894K | Direct | Nov 16, 2023 (2d) |
| Feb 14, 2023 | RYTM | ↓ Sell | 554 | $26.87 | $15K | Direct | Feb 14, 2023 (0d) |
| Feb 9, 2023 | RYTM | ↓ Sell | 921 | $27.66 | $25K | Direct | Feb 13, 2023 (4d) |
| Feb 15, 2022 | RYTM | ↓ Sell | 557 | $6.10 | $3K | Direct | Feb 15, 2022 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RYTM insiders
Open-market trades in the last 12 months
About Joseph Shulman's insider trades
Joseph Shulman is Chief Technical Officer at Rhythm Pharmaceuticals (RYTM). Since Feb 15, 2022, Joseph has reported no open-market purchases and 26 sales worth $15.7M on SEC Form 4. In the last 12 months: 1 sale ($608K).
Their filings also include option exercises (23 filings), grants and awards (5 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.